USADA announced today that Blaine Terry, of Spicewood, Texas, an athlete in the sport of weightlifting, has accepted a four-year period of ineligibility for an anti-doping rule violation.
Terry, 38, tested positive for an anabolic agent, as well as GW1516 metabolites GW1516 sulfoxide and GW1516 sulfone, as the result of a urine sample collected in-competition at the Virus Weightlifting Series 2 on August 30, 2025, where he placed third in the 94kg weight class. Terry’s urine sample was analyzed using a specialized test known as Isotope Ratio Mass Spectrometry (IRMS), that unequivocally differentiates between anabolic androgenic steroids (AAS) naturally produced by the body and AAS of synthetic origin. The IRMS analysis was consistent with the exogenous origin of testosterone and/or its metabolites in Terry’s sample.
Testosterone and its metabolites are non–Specified Substances in the class of Anabolic Agents, and GW1516 and its metabolites are non–Specified Substances in the class of Hormone and Metabolic Modulators. Both substances are prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policies, and the International Weightlifting Federation Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
Terry’s four-year period of ineligibility began on September 16, 2025, the date he was provisionally suspended. In addition, Terry has been disqualified from all competitive results obtained on and after August 30, 2025, the date his positive sample was collected, including forfeiture of any medals, points and prizes.
In an effort to aid athletes, as well as support team members such as parents, coaches, and medical professionals in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.
In addition, USADA manages a drug reference hotline, Global Drug Reference Online (GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as a supplement guide, a nutrition guide, a clean sport handbook, and periodic alerts and advisories.
USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by text at 87232 (“USADA”), by email at playclean@USADA.org, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, email Media@USADA.org.
